front 1 It is a sustained, reproducible inc in BP that could lead to cardiovascular problem, renal dse; blindness | back 1 Hypertension |
front 2 It is the most common dse | back 2 Hypertension |
front 3 What are the combination of several abnormalities that causes HTN? | back 3
|
front 4 What kind of HTN when Pt in whom no specific cause of HTN? | back 4 essential hypertension |
front 5 What are the specific causes of HTN? | back 5
|
front 6 normal control of BP - short term | back 6 baroreceptor reflex |
front 7 normal control of BP - long term | back 7 kidneys |
front 8 possible mechanism in essential hypertension | back 8
|
front 9 <12 mm systolic; <80 mmHg diastolic | back 9 Normal BP |
front 10 120-129 systolic; <80 mmHg diastolic | back 10 Elevated BP |
front 11 130 - 139 systolic or 80-89 mmHg | back 11 Stage 1 Hypertension |
front 12 > 140 systolic; > 90 mmHg diastolic | back 12 Stage 2 |
front 13 6 Major Categories of Drugs for HTN | back 13
|
front 14 It decreases the plasma fluid volume @ kidneys | back 14 DIURETICS |
front 15 It decreases sympathetic influence on: heart &/or peripheral vasculature @ various sites w/in sympathetic division of ANS? | back 15 SYMPATHOLYTIC DRUGS |
front 16 It lower vasuclar resistance by directly vasodilating @ peripheral vessels? | back 16 VASODILATORS |
front 17 These are ACE inhibitory - prevents conversion of nagiotensin I to angiotensin II receptor blockers. | back 17 inhibition of renin-angiotensin system |
front 18 These dec vascular smooth-mm cxn, dec myocardial force; rate of cxn | back 18 calcium channel blockers |
front 19 MOA: inc formation and excretion fo renal, and inc renal excretion of water; sodium; dec fluid volume lowers blood pressure | back 19 diuretics |
front 20 what are the 3 classification of diuretics? | back 20
|
front 21 It act primarily on early portion of DCT of nephron; inhibit sodium reabsorption | back 21 thiazide diuretics |
front 22 it act primarily on ascending limb of loob of Henle, which inhibits reabsorption of sodium; chloride thus prevents reabsorption of water | back 22 loop diuretics |
front 23 this prevents secretion into the distal tubule | back 23 potassium sparring |
front 24 diuretic drugs used to treat HTN | back 24
|
front 25 loop diuretics for HTN | back 25
|
front 26 potassium-sparring diuretics | back 26
|
front 27 what are the adverse effect of diuretics? | back 27
|
front 28 it is the increase in sympathetic activity may be an underlying factor in essential htn, can be classified according to where and how they interrupt sympathetic activity | back 28 sympatholytic drugs |
front 29 it is the mainstay in treatment of HTN, well tolerated by most pt, incidence of side effects are low | back 29 beta blockers |
front 30 this exerts primary effect on heart; dec HR; force of myocardia cxn; general dec sympathetic tone often complement effects of other anti-HTN | back 30 beta blockers - sympatholytic drugs |
front 31 what are the 4 theories of beta blocker - sympatholytic drugs? | back 31
|
front 32 specific agents of beta blockers - sympatholytic drugs | back 32
|
front 33 beta blockers - selective for beta 1 receptors (cardioselective) | back 33
|
front 34 beta blocker - which are partial agonists, intrinsic sympathomimetic activity | back 34 pinodolol, acebutolol |
front 35 beta blocker - which are membrane stabilizing activity | back 35 labetalol, propranolol |
front 36 beta blocker - which are peripheral vasodilator and cardiac beta blockade | back 36 labetalol, newer beta blockers |
front 37 what are the adverse effects of beta blocker - sympatholytic drugs | back 37
|
front 38 this blocks alpha 1 adrenergic receptor on vascular smooth mm, ability to improve blood lipid profiles and produce favorable effect on glucose metabolism; insulin resistance | back 38 alpha blockers - sympatholytic drugs |
front 39 indication for mild to moderate HTN, which acts directly to tissues - mediate inc BP, peripheral vasculature | back 39 alpha blockers - sympatholytic drugs |
front 40 can also be used to treat the symptoms of | back 40 alpha blockers - sympatholytic drugs |
front 41 specific agents: alpha blockers - sympatholytic drugs | back 41
|
front 42 what are the adverse effects of alpha blocker - sympatholytic drugs | back 42
|
front 43 this is an adverse effect of alpha blocker when peripheral vascular
resistance | back 43 reflex tachycardia |
front 44 this is an adverse effect of alpha blocker wherein blockade of
alpha-1 receptors in | back 44 orthostatic HOTN |
front 45 this are drugs that inhibit release of norepinephrine from
presynaptic | back 45 presynaptic adrenergic inhibitors |
front 46 MOA: : prevent normal physiologic release of | back 46 presynaptic adrenergic inhibitors |
front 47 what are the specific agents of presynaptic adrenergic inhibitors? | back 47
|
front 48 This only drug in presynaptic adrenergic inhibitors that is
still | back 48 reserpine |
front 49 adverse effects of presynaptic adrenergic inhibitors | back 49
|
front 50 this drug inhibit sympathetic discharge from | back 50 centrally acting agents |
front 51 specific agents of centrally acting | back 51
|
front 52 adverse effect of centrally acting agents | back 52
|
front 53 these are drugs that block synaptic transmission @autonomic ganglia
will dramatically; effectively reduce BP by | back 53 ganglionic blockers |
front 54 essentially nicotinic cholinergic | back 54 ganglionic blockers |
front 55 most of such drugs are no longer | back 55 ganglionic blockers |
front 56 MOA: | back 56 ganglionic blockers |
front 57 what is the indication of ganglionic blockers? | back 57 hypertensive crisis |
front 58 what are the specific agents of ganglionic blockers? | back 58
|
front 59 what are the adverse effect of ganglionic blockers? | back 59
|
front 60 these are drugs that directly vasodilate the | back 60 vasodilators |
front 61 these drugs exerts inhibitory effect: vascular smooth-mm cells, inhibit smooth mm cxn by inc intracellular production of 2nd messengers and also inc amounts of cGMP, inhibit fxn of contractile process in vascular smooth-mm cell - leading to vasodilation | back 61 vasodilators |
front 62 MOA: | back 62 vasodilators |
front 63 specific agents of vasodilators | back 63
|
front 64 adverse effect of vasodilators | back 64
|
front 65 this is an adverse effect of vasodilators whi often occurs because
the baroreceptor | back 65 reflex tachycardia |
front 66 involves several endogenous components | back 66 angiotensin converting enzyme inhibitors |
front 67 an enzyme produced primarily in the | back 67 renin |
front 68 a peptide that is produced by the liver and | back 68 angiotensinogen |
front 69 MOA: inhibits enzyme that converts | back 69 angiotensin converting enzyme inhibitors |
front 70 it is an indication of mild to moderate HTN; used alone of in combination | back 70 angiotensin converting enzyme inhibitors |
front 71 what are the advantages of angiotensin converting enzyme inhibitors? | back 71
|
front 72 specific agents of angiotensin converting enzyme inhibitors? | back 72
|
front 73 what are the adverse effect of angiotensin converting enzyme inhibitors | back 73
|
front 74 these are drugs recognized as being beneficial in the treatment of
essential HTN where calcium appears to play a role in activating the
contractile element in | back 74 calcium channel blockers |
front 75 MOA: 1. Blocks calcium entry into vascular | back 75 calcium channel blockers |
front 76 specific agents of calcium channel blockers | back 76
|
front 77 Adverse Effects of calcium channel blockers | back 77
|